Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating cancer with TrkA receptor tyrosine kinase antagonists

Methods for treating cancer with TrkA receptor tyrosine kinase antagonists

US Patent 9855265 · Granted Jan 2, 2018

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions of protein receptor tyrosine kinase inhibitors2019
Crystalline forms of tyrosine kinase inhibitors and their salts2019
Crystalline forms of tyrosine kinase inhibitors and their salts2018
Crystalline forms of tyrosine kinase inhibitors and their salts2018
Method for treating pain syndrome and other disorders2017
Compositions of protein receptor tyrosine kinase inhibitors2017
Crystalline forms2017
Crystalline forms of tyrosine kinase inhibitors and their salts2017
Method for treating pain syndrome and other disorders2016
Crystalline forms of tyrosine kinase inhibitors and their salts2016
TrkA receptor tyrosine kinase antagonists and uses thereof2016
Compositions of protein receptor tyrosine kinase inhibitors2015